CYP2C19 and CYP3A4 gene variants and schizophrenia in Armenian patients

被引：0
|
作者：
Butenko, E. V. [1 ]
Mamedov, R. F. O. [1 ]
Ghazaryan, H. K. [2 ]
Zakharyan, R. V. [3 ]
机构：
[1] Southern Fed Univ, Rostov Na Donu, Russia
[2] Inst Mol Biol NAS RA, Yerevan, Armenia
[3] Russian Armenian Univ, Inst Mol Biol NAS RA, Yerevan, Armenia
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2019年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P09.046B
引用
收藏
页码：269 / 270
页数：2
相关论文
共 50 条
  • [41] Pharmacogenetics of CYP3A4, CYP3A5, CYP2C8 and CYP2C19 and Their Influence on Tacrolimus Pharmacokinetics in Renal Transplant Recipients
    Wang, Zijie
    Han, Zhijian
    Tao, Jun
    Chen, Hao
    Li, Sun
    Tan, Ruoyun
    Gu, Min
    TRANSPLANTATION, 2018, 102 : S281 - S281
  • [42] Defining screening panel of functional variants of CYP1A1, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 genes in Serbian population
    Ivan Skadrić
    Oliver Stojković
    International Journal of Legal Medicine, 2020, 134 : 433 - 439
  • [43] Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago
    Daniele Jones
    Shana Persad-Ramdeensingh
    Sheherazade Crystal Abrahim
    Naveen Seecheran
    Rajini Rani Haraksingh
    Cardiology and Therapy, 2024, 13 : 191 - 203
  • [44] Prevalence of CYP2C19*2 and CYP2C19*3 Allelic Variants and Clopidogrel Use in Patients with Cardiovascular Disease in Trinidad & Tobago
    Jones, Daniele
    Persad-Ramdeensingh, Shana
    Abrahim, Sheherazade Crystal
    Seecheran, Naveen
    Haraksingh, Rajini Rani
    CARDIOLOGY AND THERAPY, 2024, 13 (01) : 191 - 203
  • [45] Effect on emergence from anesthesia following induction with diazepam and its association with CYP2C9, CYP2C19 and CYP3A4 gene polymorphisms
    Mittal, Tulika
    Badhe, Vk
    Badhe, Divekar
    Ahluwa, Pallavi
    Mittal, Balraj
    Mittal, Rama
    ANAESTHESIA PAIN & INTENSIVE CARE, 2024, 28 (01) : 126 - 138
  • [46] Association of CYP2C19, CYP3A4 and ABCC2 polymorphisms and voriconazole plasma concentrations in Uygur pediatric patients
    Zhao, Ting
    Shen, Hao
    Zhang, Hui-lan
    Feng, Jie
    Liu, Si-ming
    Wang, Ting-ting
    Li, Hong-jian
    Yu, Lu-hai
    PHARMACOGENOMICS, 2023, 24 (03) : 141 - 151
  • [47] Inhibition of CYP2C19 and CYP3A4 by Omeprazole Metabolites and Their Contribution to Drug-Drug Interactions
    Shirasaka, Yoshiyuki
    Sager, Jennifer E.
    Lutz, Justin D.
    Davis, Connie
    Isoherranen, Nina
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (07) : 1414 - 1424
  • [48] Identification and in silico prediction of metabolites of the model compound, tebufenozide by human CYP3A4 and CYP2C19
    Shirotani, Naoki
    Togawa, Moe
    Ikushiro, Shinichi
    Sakaki, Toshiyuki
    Harada, Toshiyuki
    Miyagawa, Hisashi
    Matsui, Masayoshi
    Nagahori, Hirohisa
    Mikata, Kazuki
    Nishioka, Kazuhiko
    Hirai, Nobuhiro
    Akamatsu, Miki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (20) : 6594 - 6601
  • [49] CYP2C19*2 and CYP2C19*3 allelomorphism in Turkish population
    Dogan, Ali
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 239 : 12 - 12
  • [50] Effect of High-Dose Esomeprazole on CYP1A2, CYP2C19, and CYP3A4 Activities in Humans: Evidence for Substantial and Long-lasting Inhibition of CYP2C19
    Kaartinen, Taavi J. K.
    Tornio, Aleksi
    Tapaninen, Tuija
    Launiainen, Terhi
    Isoherranen, Nina
    Niemi, Mikko
    Backman, Janne T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (06) : 1254 - 1264
12345